Pacific Biosciences Of California | PACB - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Agilent USD 1.81B 49M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Danaher USD 5.7B 1.09B 2026-03
General Electric Aerospace USD 10.98B 1.41B 2026-03
Illumina USD 1.42B 368M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
Pacific Biosciences Of California USD 56.27M 223.23M 2026-03
Quidel USD 140.4M 29.4M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 462M 125.83M 2026-03